Trials / Recruiting
RecruitingNCT06562153
fMRI Accelerated TMS Depression
Tracking Brain Imaging Changes in Depression Over Clinical Accelerated Transcranial Magnetic Stimulation (TMS) Therapy at the Individual Level
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (estimated)
- Sponsor
- Medical University of South Carolina · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to investigate whether phenotypic-related brain states revealed by a novel INSCAPE ("Individualized Network-based Single-frame Coactivation Pattern Estimation") neuroimaging method in Major Depressive Disorder (MDD) patients can track brain recovery of MDD patients over an accelerated antidepressant transcranial magnetic stimulation (TMS) treatment.
Detailed description
The aim of this study is to use magnetic resonance imaging (MRI) to capture images of participants' brains and apply an image processing method called INSCAPE to assess brain states. This study will recruit participants who are scheduled to receive accelerated Transcranial Magnetic Stimulation (TMS) therapy for Major Depressive Disorder (MDD). Participation in this study involves two visits, each including a 30-minute MRI scan. The interval between each visit is about one week. Depressed participants will also complete mood assessments at various intervals while they are receiving accelerated TMS for depression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Neuroimaging with Magnetic Resonance Imaging (MRI) | MRI will be used to observe brain states over time. |
Timeline
- Start date
- 2024-09-23
- Primary completion
- 2026-08-05
- Completion
- 2026-08-05
- First posted
- 2024-08-20
- Last updated
- 2025-10-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06562153. Inclusion in this directory is not an endorsement.